Latest filing published 07 Mar 2024 for Cue Health Inc., €2,474.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ayub K. Khattak, listed as chief executive, appears in our data through filings on Cue Health Inc. shares, published by SEC (Form 4). Over a trading history stretching from 24 September 2021 to 5 March 2024, the count stands at 21 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 7 March 2024 with a share grant (€2,474) in Cue Health Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations